ask="56.02"
ask_size="100"
average_daily_volume="1106840"
bid="37.50"
bid_size="100"
book_value="3.62"
change="-0.36"
change_from_200_day_moving_average="-3.17"
change_from_50_day_moving_average="0.45"
change_from_52_week_high="-12.43"
change_From_52_week_low="10.54"
change_in_percent="-0.84%"
close="42.72"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="43.14"
high_52_weeks="55.15"
last_trade_date="2/24/2017"
last_trade_price="42.72"
last_trade_size="29724"
last_trade_time="4:00pm"
low="41.89"
low_52_weeks="32.18"
market_capitalization="3.72B"
moving_average_200_day="45.89"
moving_average_50_day="42.27"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="42.78"
pe_ratio="N/A"
peg_ratio="0.51"
percent_change_from_200_day_moving_average="-6.91%"
percent_change_from_50_day_moving_average="+1.06%"
percent_change_from_52_week_high="-22.54%"
percent_change_from_52_week_low="+32.75%"
previous_close="43.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.89"
price_per_sales="250.19"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="651609"
weeks_range_52="32.18 - 55.15"
